These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6370833)

  • 1. Cellular basis of allograft rejection.
    Ascher NL; Hoffman RA; Hanto DW; Simmons RL
    Immunol Rev; 1984; 77():217-32. PubMed ID: 6370833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis of the lymphoid cells mediating skin allograft rejection. Mediation of graft rejection in vivo by cloned Lyt-1+2- proliferative, noncytotoxic long-term cell lines.
    Kim B; Rosenstein M; Weiland D; Eberlein TJ; Rosenberg SA
    Transplantation; 1983 Nov; 36(5):525-32. PubMed ID: 6356516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration and cell recruiting activity of specifically sensitized lymphocytes in sponge matrix allografts.
    Hopt UT; Sullivan W; Hoffman R; Simmons RL
    Transplantation; 1980 Dec; 30(6):411-6. PubMed ID: 6162257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions.
    Hanto DW; Hopt UT; Hoffman R; Simmons RL
    Transplantation; 1982 May; 33(5):541-6. PubMed ID: 7090043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lymphokine in islet allograft rejection.
    Hao LM; Wang Y; Gill RG; La Rosa FG; Talmage DW; Lafferty KJ
    Transplantation; 1990 Mar; 49(3):609-14. PubMed ID: 1969186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
    Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
    Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte recruitment, regional blood flow, and vascular permeability at sites of allogeneic cellular interactions.
    Hanto DW; Hopt UT; Hoffman R; Simmons RL
    J Immunol; 1982 Dec; 129(6):2437-43. PubMed ID: 7142698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of allograft tumor immunity by isotype-like suppression of antigen-specific T cell factors.
    Van Loveren H; De Weger RA; Garssen J; Los G; Askenase PW
    Transplantation; 1989 Mar; 47(3):504-12. PubMed ID: 2466354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ effector mechanisms in rat kidney allograft rejection. III. Kinetics of the inflammatory response and generation of donor-directed killer cells.
    Häyry P; von Willebrand E; Soots A
    Scand J Immunol; 1979; 10(2):95-108. PubMed ID: 386484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity in allograft rejection: role of lymphocyte subpopulations and T-cell subsets in rat cardiac allograft rejection.
    Oluwole SF; Engelstad K; Hardy MA
    Cell Immunol; 1989 Nov; 124(1):28-37. PubMed ID: 2509080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells mediating allograft rejection.
    Hall BM; Dorsch SE
    Immunol Rev; 1984; 77():31-59. PubMed ID: 6232202
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
    Perez M; Edelson R; Laroche L; Berger C
    J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of freshly inplanted alloantigen in vivo to attract circulating allosensitized lymphocytes.
    Migliori RJ; Hoffman RA; Gruber SA; Debe EC; Ascher NL; Simmons RL
    Transplantation; 1988 Feb; 45(2):452-8. PubMed ID: 3125637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine suppression of lymphocyte recruitment, regional blood flow, and vascular permeability at sites of allogeneic cellular interactions.
    Hanto DW; Harty JT; Hoffman R; Simmons RL
    Surgery; 1983 Aug; 94(2):218-24. PubMed ID: 6879440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory mechanisms of allograft rejection.
    Häyry P; von Willebrand E; Parthenais E; Nemlander A; Soots A; Lautenschlager I; Alfoldy P; Renkonen R
    Immunol Rev; 1984; 77():85-142. PubMed ID: 6232204
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitized B lymphocytes contribute to acute allograft rejection.
    Gritsch HA; Grimm PC; Ettenger RB; Rosenthal JT
    J Surg Res; 1991 Sep; 51(3):204-9. PubMed ID: 1881134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.